Hosseini Seyed Younes, Mallick Rahul, Mäkinen Petri, Ylä-Herttuala Seppo
A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Bacteriology and Virology Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Hum Gene Ther. 2024 Sep;35(17-18):649-668. doi: 10.1089/hum.2024.043. Epub 2024 Jul 1.
As the most versatile and precise gene editing technology, prime editing (PE) can establish a durable cure for most human genetic disorders. Several generations of PE have been developed based on an editor machine or prime editing guide RNA (pegRNA) to achieve any kind of genetic correction. However, due to the early stage of development, PE complex elements need to be optimized for more efficient editing. Smart optimization of editor proteins as well as pegRNA has been contemplated by many researchers, but the universal PE machine's current shortcomings remain to be solved. The modification of PE elements, fine-tuning of the host genes, manipulation of epigenetics, and blockage of immune responses could be used to reach more efficient PE. Moreover, the host factors involved in the PE process, such as repair and innate immune system genes, have not been determined, and PE cell context dependency is still poorly understood. Regarding the large size of the PE elements, delivery is a significant challenge and the development of a universal viral or nonviral platform is still far from complete. PE versions with shortened variants of reverse transcriptase are still too large to fit in common viral vectors. Overall, PE faces challenges in optimization for efficiency, high context dependency during the cell cycling, and delivery due to the large size of elements. In addition, immune responses, unpredictability of outcomes, and off-target effects further limit its application, making it essential to address these issues for broader use in nonpersonalized gene editing. Besides, due to the limited number of suitable animal models and computational modeling, the prediction of the PE process remains challenging. In this review, the fundamentals of PE, including generations, potential, optimization, delivery, barriers, and the future landscape of the technology are discussed.
作为最通用、最精确的基因编辑技术,碱基编辑(PE)可为大多数人类遗传疾病建立持久的治疗方法。基于编辑机器或碱基编辑引导RNA(pegRNA)已开发出几代PE,以实现任何类型的基因校正。然而,由于处于开发早期,PE复合元件需要进行优化以实现更高效的编辑。许多研究人员已考虑对编辑蛋白以及pegRNA进行智能优化,但通用PE机器目前的缺点仍有待解决。对PE元件进行修饰、对宿主基因进行微调、操纵表观遗传学以及阻断免疫反应可用于实现更高效的PE。此外,参与PE过程的宿主因子,如修复和先天免疫系统基因,尚未确定,PE对细胞环境的依赖性仍知之甚少。鉴于PE元件体积较大,递送是一项重大挑战,通用病毒或非病毒平台的开发仍远未完成。具有逆转录酶缩短变体的PE版本仍然太大,无法装入常见的病毒载体。总体而言,PE在效率优化、细胞周期中的高环境依赖性以及由于元件体积大导致的递送方面面临挑战。此外,免疫反应、结果的不可预测性和脱靶效应进一步限制了其应用,因此必须解决这些问题,以便在非个性化基因编辑中更广泛地使用。此外,由于合适的动物模型和计算模型数量有限,PE过程的预测仍然具有挑战性。在这篇综述中,将讨论PE的基本原理,包括几代产品、潜力、优化、递送、障碍以及该技术的未来前景。